Skip to content
  • Business
  • Technology
  • Finance
  • Health
  • National
  • Press Release
Financial Telegraph

Financial Telegraph

  • Business
  • Technology
  • Finance
  • Health
  • National
  • Press Release

Breaking News

Liquide’s Draws 1,500+ Seasoned Traders to Conclave 5.0 as AI Reshapes India’s Trading Landscape

Sollfege Smart Electronics’ IPO to Open on September 30, 2026; Company Aims to Raise Rs. 21.78 Crore

Dr. A.K. Dwivedi Presents Second Edition of ‘Homeopathy for Anemia’ to CM Mohan Yadav

Eventions’ IPO to Open on September 30, 2026; Company Aims to Raise Rs. 38.12 Crore

Blood Cancer in 2026: Why Treatment Decisions Are More Personal Than Ever

Bamboo Pitched as ‘Green Gold’ for Rural India at Mumbai Summit

HR Conclave 2026 at RGIPT Bengaluru Highlights Leadership, AI and Skills for the Future of Work

Steamhouse India Limited Secures Rs 311 Crore EPC Mandate for 300 TPH Steam Project at Bulk Drug Park, Una

Sparsh Pearl honoured as an Iconic Brand by ET Edge (The Times Group)

Asia Leadership Summit 2026 in Bengaluru Explores a New Leadership Paradigm: “The Whole Leader, Not More… WHOLE”

Tag: Stock Market

Davangere Sugar Shares: Analyst Note Sees 234% Upside to ₹10 Target Amid Sugar Cycle Tailwinds
Business

Davangere Sugar Shares: Analyst Note Sees 234% Upside to ₹10 Target Amid Sugar Cycle Tailwinds

Rahul Malhotra August 24, 2026

New Delhi [India], August 24: Davangere Sugar Industries Ltd (BSE: 543267) has emerged as a potential high-risk, high-reward opportunity, with an investor note assigning a BUY rating and a target … Read More

davangere sugarInvestment opportunitiesStock MarketSugar IndustrySugar Stocks

Recent Posts

  • Liquide’s Draws 1,500+ Seasoned Traders to Conclave 5.0 as AI Reshapes India’s Trading Landscape
  • Sollfege Smart Electronics’ IPO to Open on September 30, 2026; Company Aims to Raise Rs. 21.78 Crore
  • Dr. A.K. Dwivedi Presents Second Edition of ‘Homeopathy for Anemia’ to CM Mohan Yadav
  • Eventions’ IPO to Open on September 30, 2026; Company Aims to Raise Rs. 38.12 Crore
  • Blood Cancer in 2026: Why Treatment Decisions Are More Personal Than Ever
  • Business
  • Technology
  • Finance
  • Health
  • National
  • Press Release
Proudly powered by WordPress | Theme: TrustNews | By Theme Freesia.